Urinary bladder tumors in cats, unlike in dogs, usually appear outside of the trigonal region. These tumors are confused with urinary tract infections associated with hematuria in a clinical sense. Cytological examination and ultrasound (USG) imaging techniques are very valuable, but histopathological approach is the golden key. In this case, a 17-year-old, mixed, neutered male cat was brought to the clinic with non-obstructive hematuria attacks. A superficial hypoechoic mass located at the apex of the urinary bladder was detected via USG imaging technique. No discernible findings were seen by cytological examination. After removal of the suspected area, the biopsy specimen was presented to the pathology department for histopathological examination. Histopathological examination revealed transitional cells covering entire surface of the mucosal epithelium and showing growth into the lumen, and they were characterized by mild anisocytosis and anisokaryosis. The patient was diagnosed as in-situ non-papillary, non-infiltrating type of transitional cell carcinoma (in-situ carcinoma). These tumors are quite rare and have better prognosis. The condition of the patient was completely resolved without medical treatment in the postoperative period. When this case report was prepared, 6 months after the operation, there was no recurrence in the patient. Contrary to infiltrative urinary bladder tumors, in-situ carcinoma could be completely cured by surgery. Therefore the case was found worthy to be presented.
Tumors of the urinary bladder is commonly seen in dogs, cats and cattle. Bovine tumors are generally found in association with enzootic hematuria, and bracken fern (Pteridium aquilinum) is generally presented as one of the main causative carcinogens for the occurrence of these tumors. In dogs, these tumors represent 1% of all canine neoplasms and they are even less frequent in cats (1). Epithelial tumors are most commonly seen in cats and dogs and are composed of papilloma, adenoma and carcinoma, in which transitional cell carcinomas (TCC) are most commonly diagnosed in dogs, and occur less frequently in cats (2). On the other hand, TCC has also been reported in some captive fishing cats (Prionailurus viverrinus) (3, 4).
TCC is usually seen in old dogs aged 9 to 11 years averagely (2). Adult cats are found more frequently affected and the frequency increase with age (5). Although there are no significant differences between female and male TCC, females, especially neutered females, have a higher risk than males (6). The reason for that is thought to be decreased frequency of urination in females which results in longer exposure of the causative carcinogens with the bladder epithelium (2). In a study, neutered male cats are presented as more commonly affected, and they are classified as high grade according to canine classification system (7). Other risk factors for developing TCC in dogs can be multifactorial. Between them, exposure to insecticides for flea and tick control, exposure to marshes sprayed with insecticides for mosquito control, obesity, female sex, cyclophosphamide administration (8) and some breeds (such as Scottish, West Highland White, and Fox Terriers, Shetland Sheepdogs, and Beagles)(2).
Almost all cases show clinical problems (9), such as hematuria, pollakiuria, cystitis, or dysuria, but none of them can be seen as a significant feature for bladder tumors (6). In cats, TCC tumors usually fail to be noticed until the occurrence of lower urinary tract symptoms of geriatric cats (2). Definitive diagnosis can be done by the cytological, histopathological demonstration of the neoplastic cells from the bladder mass or by imaging techniques using radiography or ultrasonography, or visualization of the mass by contrast cystography or laparotomy (10). Between these methods, contrast cystography is found useful for the visualization of the bladder tumors (6). USG (11) and cytological examination (12) can rapidly lead to detect the primary tumors of the urinary bladder. But grading schemes of the tumor can only be performed by histopathological examination (2). In addition, cytological examination may not give reliable results, as TCC is commonly composed of inflammation and it cannot be possible to differentiate the neoplastic transitional cells from inflammatory cells (10).
Transitional cell carcinomas in dogs are usually located in the trigone areas of the bladder wall, because urine is pooled in this area that leads to longer exposure of the epithelium with the toxins in urine. However, the localization can be found outside of the trigone (7). Histopathological features of the TCC show various variants which are characterized by various degree of changes in transitional epithelium. Most of the TCCs are found anaplastic, invasive and tend to metastases, thus they can be classified as high grade and are accepted as one of the most malignant tumors (2). Metastasis can be detected radiographically or by gross examination at necropsy (6, 13). Metastasis have been reported in lungs, lymph nodes, bones (13) and rarely in joints (14) and many
organs will have metastasis if they are searched thoroughly in gross inspection.
The features of metastatic potential can be put in order as: nonpapillary (flat, sessile), infiltrating, vascular invasion, desmoplasia, minimal lymphoid inflammation and urethral involvement (15). Tumor grading scheme is dependent on growth patterns, cell type, degree of differentiation, depth of invasion and a strong peri-tumoral lymphocytes infiltration (16). The staging of the bladder carcinoma is performed by TNM system. In a review study, staging of the tumor is considered useful to determine the prognosis and to provide better treatment plan. Median survival time for dogs with different stages has been emphasized that for cases with T3 tumors have 118 days median survival, and 218 days for T1 or T2 tumors. N0 tumors have median survival time of 234 days, but N1 tumors have median survival time of 70 days. While dogs with distant metastasis have median survival time of 105 days, it is 203 days for dogs without distant metastasis (10). On the other hand, in-situ carcinomas do not have metastasis, they represent the most well-differentiated variant. The tumor cells proliferate in basal membrane and remain there, they do not tend to breach the basal membrane. Therefore, in- situ carcinomas can be found as an incidental lesion at autopsy (2).
In this report, the case was classified according to the World Health Organization (WHO) (15) system of canine transitional cell carcinomas that are classified into four groups: a. Papillary and infiltrative, b. Papillary and non-infiltrative, c. Non-papillary and infiltrative, d. Non- papillary and non-infiltrative (in-situ carcinoma).
MATERIAL & METHOD
A 17-year-old, mixed, neutered male cat with the complaints of hematuria and a recurrent chronic cystitis was brought to the clinic for examination. Ultrasonographic (USG) examination was performed to observe if there was any obstruction in this region. A mass suspected of neoplasia was detected. Regarding the findings of USG examination, a smear was prepared from the urine and stained with May Grünwald-Giemsa to distinguish the lesion from neoplasia. Afterwards, the suspicious mass on the wall of urinary bladder of the patient was totally extirpated and sent to the pathology department for histopathological examination. After the 24h fixation, the specimen was routinely processed, embedded into paraffin blocks. Sections of 4 μm thickness were cut from the blocks, stained by Hematoxylin-Eosin (H&E) and examined by light microscopy.
FINDINGS AND DISCUSSION
Clinical Findings: The patient had already prolonged cystitis problems. In the detailed clinical examination, the cat was found to be slightly tense on abdominal palpation, with a moderately sized, hard bladder and had moderate to severe, intermittent and painless hematuria, dysuria and mild constipation. Besides these findings, the patient had loss of appetite.
After histopathological evaluations, cat was re- examined for the clinic staging and revealed neither lymph node involvement (N:0) nor distant metastasis (M:0)
Ultrasonographic Findings: The patient was examined by USG and revealed no obstructive mass at the entrance of the urethra; however, a superficial mass of 1.22 x 2.60 cm was detected on the wall of the urinary bladder far from the trigonal region. The mass was characterized by increased echogenicity located in the distal portion of the urinary bladder (Fig. 1, 2).
Cytological Findings: Cytological examination of the urine smear revealed dense erythrocytes (Fig. 3, 4), moderate number of neutrophiles (Fig. 4) and very small numbers of desquamative transitional cells (Fig. 3) and debris. But transitional cells showed no significant atypia.
Histopathological Findings: The tissue specimen of the urinary bladder showed prominent proliferation in transitional cells (Fig. 5) through the lumen. Neoplastic transitional cells covered the entire mucosal surface, but remained only in the lamina propria and did not breach the basement membrane. Neoplastic cells were found in ovoid morphology and had eosinophilic cytoplasm. There was mild anisokaryosis and a small amount of mitosis (Fig. 6, 7). No vascular or lymphatic invasion was found. There were multiple foci of hemorrhages in mucosa. Multiple hematomas, lymphocytic and neutrophilic infiltration, large necrotic areas (Fig. 5, star) and calcification foci (Fig. 5, arrow) were observed in submucosa and muscular layers.
According to clinical, USG and histopathological findings, the case was diagnosed as non- infiltrative transitional cell carcinoma (in-situ carcinoma).
Transitional cell carcinoma has previously been reported in geriatric cats (5) with symptoms of chronic lower urinary tract disease (7). With old age and prolonged clinical symptoms, this condition resembled the patient observed in this case.
In this case report, the neoplastic mass was also found outside the trigonal region. It has already been reported that in contrast to the dogs, bladder tumors can also be located outside of the trigonal region in cats (7), due to their anatomical features (17).
As diagnostic methods, several imaging techniques, such as radiography, USG or cystography have been used in other studies (6, 16, 7). In the present case report, the mass was detected by USG, and then cytological examination from the urine sample was performed to detect the neoplastic cells. But the cytological examination in this study failed to detect the neoplastic cells. It has already been mentioned that cytological examination can be effective only in cases up to 20-30%, if the tumor cells are found in the urine sample. However, negative results cannot be interpreted as the absence of neoplasia, if there is no neoplastic cells in the smear (2). Therefore, in this case the confirmation of the diagnosis was performed by further histopathological examination. Our histopathological findings showed that the tumor had severe proliferation of the neoplastic transitional cells within the surface of the epithelium. No deep infiltration or vascular or lymphatic invasion was determined. According to WHO classification system, the case, based on these histopathological findings, was diagnosed as non-infiltrative transitional cell carcinoma (in-situ carcinoma), which is one of the rarest variant of the TCC in cats and is likely attributed as an early neoplastic transformation of the bladder epithelium (2). In contrast to this case, other variants of TCC are more anaplastic (15). Between the other variants of TCC, the most common type of the bladder tumors is assumed as papillary and infiltrating TCC in domestic animals. They are very aggressive and have poor prognosis. Indeed, the classification system of WHO is available for dogs, but there was no validated system for cats in use, therefore, we also applied the canine classification system to this case report as a study by WILSON et al. (7). Using the classification system described above, the prognosis of the case was better interpreted. After the operation, the patient showed healthy prognosis. Although no medical treatment has been used for the patient in the post-operative period, no recurrence was observed during the period since the operation until today.
In conclusion, the case showed that the clinic symptoms of lower urinary tract in geriatric cats should be reconsidered for the possibility of bladder tumors. USG, cytology and histopathology have been performed as diagnostic tools in this case report and they revealed that more attention should be given because negative results revealed by cytological examination does not always mean the tumor is absent. Therefore, in this condition, the case should be confirmed by histopathology. Moreover, histopathology is required to determine the classification of the tumor to interpret the prognosis of the patient.
This case report has been prepared in collaboration with the Pathology Department of the Veterinary Medicine Faculty of Istanbul University Cerrahpasa and Ada Veterinary Clinic.
* Cianciola ER and Mohr CF. 2016. Urinary System in Jubb Kennedy, and Palmer`s Pathology of Domestic Animals. Elsiver, Missouri, 2: 462.
* Meuten DJ, Meuten TLK. 2017. Tumors of Urinary System in Tumors of Domestic Animals. 2017 John Wiley & Sons, Inc. 656-675.
* Lanfoldi JA and Terio KA. 2006. Transitional Cell Carcinoma in Fishing Cats (Prionailurus viverrinus). Vet Pathol. 43: 674-681.
* Sutherland and-Smith M, Harvey C, Campell M, McAloose D, Rideout B, Morris P. 2004. Transitional Cell Carcinomas In Four Fishing Cats (Prionailurus Viverrinus). J Zoo Wildl Med. 35(3):370–380
* Wimberly HC and Lewis RM. 1979. Transitional cell carcinoma in the domestic cat. Vet Pathol. 16: 223–228.
* Norris AM, Laing EJ, Valli VEO, Withrow SJ, Macy DW, Ogilvie GK, Tomlinson J, McCaw D, Pidgeon G, Jacobs RM. 1992. Canine Bladder and Urethral Tumors: A Retrospective Study of 115 Cases (1980-1985). J. Vet. Intern. Med. 6: 145-153.
* Wilson HM, Chun R, Larson VS, Kurzman ID, Vail DM. 2007. Clinical signs, treatments and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990–2004). J Am Vet Med Assoc. 231:101– 106.
* Lin T, Zhang H, Luo L, Li Y, Gao T, Lara J PN, de Vere White R, Lam S, Pan C. 2012. Int J Nanomed. 7: 2793-2804.
Henry CJ. Management of transitional cell carcinoma. 2003. Vet Clin Small Anim. 33:597–613.
* Léveillé R. 1998. Veterinary Clinics: Small Animal Practice. 779-82.
* Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM, Sesterhenn IA, Tachibana M, and Weider 2005. Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urology, 66:5-34.
* McCaw DL, Hogan PM, and Shaw DP. (1988) Canine urinary bladder transitional cell carcinoma with skull metastasis and unusual pulmonary metastases. Can Vet J. 29:386–388
* Colledge SL, Raskin RE, Messick JB, Reed LT, Wigle WL. 2013. Multiple joint metastasis of a transitional cell carcinoma in a dog. Vet Clin Pathol. 42: 216–220.
* 2004. International Histological Classification of Tumors of the Urinary System of Domestic Animals. Bull World Health Organ. 26-31.
* Valli VE, Norris A, Jacobs RM, Laing E, Withdrow S, Macy D, Ogilvie GK, Tomlinson J, McCaw D, Pidgeon G. 1995. Pathology of canine bladder and urethral cancer and correlation with tumor progression and survival. J Comp Path. 113:113–30.
* Dyce KM, Sack WO, Wensing CJG. 1996. Textbook of veterinary anatomy. 3rd ed. Philadelphia: WB Saunders Co.169–208.
ADA VETERINARY ONCOLOGY CLINIC Levent Mah. Sülün Sokak No: 14 1. Levent - Beşiktaş - Istanbul / TURKEY 0212 324 67 32 - email@example.com